MedTrace Logo

Electronic Cigarette Unit Price Manipulations in the Experimental Tobacco Marketplace

NCT03843047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2022-11-22

No results posted yet for this study

Summary

Electronic cigarettes (e-cigarettes) may be a safer alternative to conventional cigarettes and are available in a broad range of nicotine strengths. The overall goal of this project is to use an experimental analogue of the real-world tobacco marketplace to examine the effects of nicotine strength on e-cigarette consumption and the likelihood that current smokers will either switch to e-cigarettes (which may reduce harm) or use both products in combination (which may increase harm). Testing effects of e-cigarette nicotine strength under controlled conditions in a context that models the real world will facilitate evidence-based policies that have a net benefit to health.

Conditions

  • Tobacco Use

Interventions

DRUG

3 mg/mL nicotine strength e-liquid

Availability of 3 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace

DRUG

6 mg/mL nicotine strength e-liquid

Availability of 6 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace

DRUG

12 mg/mL nicotine strength e-liquid

Availability of 12 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace

DRUG

24 mg/mL nicotine strength e-liquid

Availability of 24 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace

Sponsors & Collaborators

  • Virginia Polytechnic Institute and State University

    lead OTHER

Principal Investigators

  • Jeff S. Stein, Ph.D. · Fralin Biomedical Research Institute at VTC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03843047 on ClinicalTrials.gov